THE cold weather can trigger a range of symptoms, with the most common being shivering. But if certain symptoms seem out of ...

Patients with chronic spontaneous urticaria experienced substantial reductions in hives and itch with briquilimab through 16 ...

P39 Compared With Reference Omalizumab in Chronic Spontaneous Urticaria: Results From a Double-Blind, Randomized, ...

Analyst Silvan Tuerkcan of JMP Securities reiterated a Buy rating on Allakos (ALLK – Research Report), with a price target of $3.00.Stay Ahead ...

Leerink Partners analyst Andrew Berens has assigned their neutral stance on BPMC stock, giving a Hold rating on January 13.Stay Ahead of the ...

The Montair LC tablet is an antiallergic tablet that relieves sneezing, itching, watery eyes, stuffy nose, and runny nose ...

To be or not to be a beekeeper: That is the question that may be answered Jan. 18 when expert Jay Martin takes part in ...

Shares of Sana Biotechnology Inc. (NASDAQ: SANA) were trading at $4.97, up $3.32, or 201%, on first results from an investigator-sponsored, first-in-human study transplanting UP-421, an allogeneic ...

Dementia, a progressive disorder that impacts memory and independence, affects millions globally. While many are aware of ...

Learn about rheumatoid vasculitis, neutrophilic dermatoses, and other rheumatoid arthritis rashes, their symptoms, and when ...

Updating peak systemic mastocytosis franchise revenue opportunity to $4 billion, catalyzed by strong AYVAKIT® (avapritin ...

Welcome to the Novartis presentation at the 43rd JPMorgan Healthcare Conference. I'm Richard Vosser, European pharma analyst with JPMorgan. It's my great pleasure to introduce Vas Narasimhan, the CEO ...